vesnarinone has been researched along with Carcinoma, Adenosquamous in 1 studies
Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, M | 1 |
| Kawamata, H | 1 |
| Harada, K | 1 |
| Nakashiro, K | 1 |
| Ikeda, Y | 1 |
| Gohda, H | 1 |
| Yoshida, H | 1 |
| Nishida, T | 1 |
| Ono, K | 1 |
| Kinoshita, M | 1 |
| Adachi, M | 1 |
1 other study available for vesnarinone and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.
Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Cell Differentiation; Cell Division; Cyclin-Depende | 1997 |